Tokai appoints Senior-Vice President Of Commercial Development
This article was originally published in Scrip
Lisa Taylor has been appointed senior vice president, commercial development of Tokai Pharmaceuticals Inc., which is focused on innovative therapies for prostate cancer and other hormonally-driven diseases. Taylor was a member of the launch team for Xtandi (enzalutamide) at Medivation Inc. where she served as vice president, commercial development.
Register for our free email digests: